vs
INVESTORS TITLE CO（ITIC）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是INVESTORS TITLE CO的1.0倍（$69.8M vs $69.5M），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -1.6%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 14.0%）
该公司是全球首家产权保险公司，前身为费城房地产产权保险公司，目前专注于为房地产交易提供产权保险相关服务，保障房地产交易中产权方的合法权益，在产权保险领域拥有悠久的发展历史与行业积累。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
ITIC vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.0倍
$69.5M
营收增速更快
RIGL
高出22.8%
-1.6%
两年增速更快
RIGL
近两年复合增速
14.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $69.5M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 13.8% | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | -1.6% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $3.97 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ITICRIGL
| Q4 25 | $69.5M | $69.8M | ||
| Q3 25 | $73.0M | $69.5M | ||
| Q2 25 | $73.6M | $101.7M | ||
| Q1 25 | $56.6M | $53.3M | ||
| Q4 24 | $70.6M | $57.6M | ||
| Q3 24 | $68.8M | $55.3M | ||
| Q2 24 | $65.4M | $36.8M | ||
| Q1 24 | $53.5M | $29.5M |
净利润ITICRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $12.2M | $27.9M | ||
| Q2 25 | $12.3M | $59.6M | ||
| Q1 25 | $3.2M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $9.3M | $12.4M | ||
| Q2 24 | $8.9M | $-1.0M | ||
| Q1 24 | $4.5M | $-8.2M |
毛利率ITICRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率ITICRIGL
| Q4 25 | 13.8% | 33.2% | ||
| Q3 25 | 20.7% | 40.9% | ||
| Q2 25 | 21.5% | 60.1% | ||
| Q1 25 | 7.2% | 23.9% | ||
| Q4 24 | 15.3% | 28.9% | ||
| Q3 24 | 16.8% | 25.4% | ||
| Q2 24 | 17.2% | 1.2% | ||
| Q1 24 | 10.8% | -23.6% |
净利率ITICRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | 16.7% | 40.2% | ||
| Q2 25 | 16.7% | 58.6% | ||
| Q1 25 | 5.6% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 13.5% | 22.5% | ||
| Q2 24 | 13.6% | -2.8% | ||
| Q1 24 | 8.5% | -27.9% |
每股收益（稀释后）ITICRIGL
| Q4 25 | $3.97 | $14.11 | ||
| Q3 25 | $6.45 | $1.46 | ||
| Q2 25 | $6.48 | $3.28 | ||
| Q1 25 | $1.67 | $0.63 | ||
| Q4 24 | $4.41 | $0.82 | ||
| Q3 24 | $4.92 | $0.70 | ||
| Q2 24 | $4.70 | $-0.06 | ||
| Q1 24 | $2.40 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $89.6M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $268.3M | $391.5M |
| 总资产 | $363.1M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资ITICRIGL
| Q4 25 | $89.6M | $155.0M | ||
| Q3 25 | $110.8M | $137.1M | ||
| Q2 25 | $90.1M | $108.4M | ||
| Q1 25 | $81.7M | $77.1M | ||
| Q4 24 | $83.8M | $77.3M | ||
| Q3 24 | $112.9M | $61.1M | ||
| Q2 24 | $111.2M | $49.1M | ||
| Q1 24 | $135.0M | $49.5M |
总债务ITICRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益ITICRIGL
| Q4 25 | $268.3M | $391.5M | ||
| Q3 25 | $278.0M | $117.6M | ||
| Q2 25 | $266.2M | $81.9M | ||
| Q1 25 | $254.4M | $18.6M | ||
| Q4 24 | $251.8M | $3.3M | ||
| Q3 24 | $271.3M | $-14.6M | ||
| Q2 24 | $261.8M | $-29.9M | ||
| Q1 24 | $254.0M | $-31.7M |
总资产ITICRIGL
| Q4 25 | $363.1M | $513.6M | ||
| Q3 25 | $363.3M | $242.5M | ||
| Q2 25 | $345.8M | $206.7M | ||
| Q1 25 | $333.8M | $176.0M | ||
| Q4 24 | $333.6M | $164.0M | ||
| Q3 24 | $352.0M | $139.4M | ||
| Q2 24 | $340.3M | $128.4M | ||
| Q1 24 | $329.5M | $126.5M |
负债/权益比ITICRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $30.9M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $25.4M | — |
| 自由现金流率自由现金流/营收 | 36.5% | — |
| 资本支出强度资本支出/营收 | 8.0% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $47.1M | — |
8季度趋势，按日历期对齐
经营现金流ITICRIGL
| Q4 25 | $30.9M | $22.0M | ||
| Q3 25 | $17.2M | $24.0M | ||
| Q2 25 | $8.9M | $30.5M | ||
| Q1 25 | $-75.0K | $-893.0K | ||
| Q4 24 | $29.8M | $14.5M | ||
| Q3 24 | $7.8M | $21.7M | ||
| Q2 24 | $8.4M | $302.0K | ||
| Q1 24 | $1.4M | $-5.0M |
自由现金流ITICRIGL
| Q4 25 | $25.4M | — | ||
| Q3 25 | $15.8M | — | ||
| Q2 25 | $7.3M | — | ||
| Q1 25 | $-1.4M | — | ||
| Q4 24 | $22.4M | — | ||
| Q3 24 | $6.1M | — | ||
| Q2 24 | $6.3M | — | ||
| Q1 24 | $-793.0K | — |
自由现金流率ITICRIGL
| Q4 25 | 36.5% | — | ||
| Q3 25 | 21.7% | — | ||
| Q2 25 | 9.9% | — | ||
| Q1 25 | -2.5% | — | ||
| Q4 24 | 31.7% | — | ||
| Q3 24 | 8.8% | — | ||
| Q2 24 | 9.7% | — | ||
| Q1 24 | -1.5% | — |
资本支出强度ITICRIGL
| Q4 25 | 8.0% | — | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 10.5% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 3.2% | — | ||
| Q1 24 | 4.2% | — |
现金转化率ITICRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 1.40× | 0.86× | ||
| Q2 25 | 0.72× | 0.51× | ||
| Q1 25 | -0.02× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 0.84× | 1.75× | ||
| Q2 24 | 0.95× | — | ||
| Q1 24 | 0.32× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
